Post-traumatic stress disorder Mental and Behavioural Disorders Post-traumatic stress disorder
Conditions
Interventions
Cognitive therapy for PTSD (CT-PTSD) is a trauma-focused cognitive behavioural treatment for posttraumatic stress disorder recommended by NICE (2018) and international treatment guidelines. It is usua
Sponsors
University of Oxford
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Post-Traumatic Stress Disorder is the main psychological problem, and the patient's priority to work on in therapy 2. Their current reexperiencing symptoms are linked to one or two discrete traumatic events that they experienced in adulthood or adolescence, or several traumatic episodes during a longer period of high threat (e.g., domestic abuse, war zone experiences) 3. Regular, private access to an internet-enabled device and reliable internet connection 4. Able to take phone calls from their therapist within normal IAPT clinic hours, and have enough time in their week to be able to log in and work on the programme regularly (i.e. at least 20 min on 3-4 days each week) 5. Able to speak, read and write English 6. If on medication for mood/anxiety, the participant agrees to remain to stay on a stable dose
Exclusion criteria
Exclusion criteria: 1. Marked clinical risk based on the service's intake assessment 2. Current dependence on alcohol or substances 3. Currently participating in another clinical research study 4. Current psychosis/bipolar affective disorder/emotionally unstable personality disorder (NB. These conditions are not typically treated within IAPT services)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery as defined in IAPT by cut-offs on the PTSD Symptom Checklist for DSM-5 (PCL-5) and Patient Health Questionnaire (PHQ-9) at the end of weekly treatment and the end of booster treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. PTSD symptoms measured with the PCL-5 completed at baseline, 12 weeks and 24 weeks. The PCL-5 is given weekly during the weekly therapy phase as is standard in IAPT services 2. Depression symptoms measured with the PHQ-9 completed at baseline, 12 weeks and 24 weeks. The PHQ-7 is given weekly during the weekly therapy phase as is standard in IAPT services 3. Anxiety symptoms measured with the Generalised Anxiety Disorder Questionnaire (GAD-7) completed at baseline, 12 weeks and 24 weeks. The GAD-7 is given weekly during the weekly therapy phase as is standard in IAPT services 4. Disability measured with the Work and Social Adjustment Scale (WSAS) completed at baseline, 12 weeks and 24 weeks. The WSAS is given weekly during the weekly therapy phase as is standard in IAPT services 5. Satisfaction with treatment assessed with the IAPT Patient Experience Questionnaire at the end of treatment Process measures: 1. Credibility of treatment measured with the Borkovec and Nau Credibility scale at 2 weeks. 2. Working alliance measured with the Working Alliance Scale completed by patients and therapists at 2 weeks 3. Appraisals of the trauma and its sequelae measured with a short version of the Posttraumatic Cognitions Inventory (PTCIs) given at baseline and weekly during the weekly therapy phase 4. Qualities of trauma memories measured with a short version of the trauma memory questionnaire (MQ) given at baseline weekly during the weekly therapy phase 5. Responses to intrusive memories measured with a short version of the Response to Intrusions Questionnaire (RIQ) given at baseline and weekly during the weekly therapy phase 6. Safety behaviours measured with a short version of the Safety Behaviours Questonnaire (SBQ) given at baseline and weekly during the weekly therapy phase 7. Diss | — |
Countries
England, United Kingdom
Outcome results
None listed